Dabigatran and Rivaroxaban Use in Atrial Fibrillation Patients on Hemodialysis
available in PMC 2016 March 17
Main Authors: | Chan, Kevin E., Edelman, Elazer R., Wenger, Julia B., Thadhani, Ravi I., Maddux, Franklin W. |
---|---|
Other Authors: | Massachusetts Institute of Technology. Institute for Medical Engineering & Science |
Format: | Article |
Language: | en_US |
Published: |
American Heart Association
2016
|
Online Access: | http://hdl.handle.net/1721.1/102945 https://orcid.org/0000-0002-7832-7156 |
Similar Items
-
Safety and efficacy of dabigatran versus warfarin in Asian patients with atrial fibrillation
by: Inche Mat, Liyana Najwa, et al.
Published: (2020) -
Factors associated with abrupt discontinuation of dabigatran therapy in patients with atrial fibrillation in Malaysia
by: Beshir, S.A., et al.
Published: (2016) -
A comparison of dabigatran and warfarin for stroke prevention in elderly Asian population with nonvalvular atrial fibrillation: an audit of current practice in Malaysia
by: Yap, Swee Hien, et al.
Published: (2017) -
A national audit on the utilization and documentation of dabigatran checklist for patients initiated on dabigatran
by: Devaraj, Navin Kumar, et al.
Published: (2019) -
A mathematical model for atrial fibrillation
by: Berger, Ronald David
Published: (2006)